CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of GSK Biologicals' dTpa-IPV Vaccine (Boostrix Polio) as a Booster Dose in 5 to 6-year-old Children.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00871000
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.764904+00:00
Published At: 2017-04-18T00:00:00+00:00
Record Updated At: 2018-06-06
Results Posted At: 2017-04-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acellular Pertussis", "Tetanus", "Diphtheria", "Poliomyelitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-06"
protocolSection.identificationModule.nctId: "NCT00871000"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety of GSK Biologicals\u0027 dTpa-IPV Vaccine (Boostrix Polio) as a Booster Dose in 5 to 6-year-old Children."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.